These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21152080)

  • 21. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
    Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
    J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protection.
    Hernandez JC; Giraldo DM; Paul S; Urcuqui-Inchima S
    PLoS One; 2015; 10(3):e0119844. PubMed ID: 25785697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.
    Surendran N; Simmons A; Pichichero ME
    Innate Immun; 2018 May; 24(4):240-251. PubMed ID: 29673285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated innate immune defenses in very premature neonates during the neonatal period.
    Marchant EA; Kan B; Sharma AA; van Zanten A; Kollmann TR; Brant R; Lavoie PM
    Pediatr Res; 2015 Nov; 78(5):492-7. PubMed ID: 26186294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood.
    De Wit D; Tonon S; Olislagers V; Goriely S; Boutriaux M; Goldman M; Willems F
    J Autoimmun; 2003 Nov; 21(3):277-81. PubMed ID: 14599853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of TLR agonist on infections bronchitis virus replication and cytokine expression in embryonated chicken eggs.
    Sharma BK; Kakker NK; Bhadouriya S; Chhabra R
    Mol Immunol; 2020 Apr; 120():52-60. PubMed ID: 32065987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
    Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
    Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response.
    Caron JE; La Pine TR; Augustine NH; Martins TB; Hill HR
    Neonatology; 2010; 97(3):266-73. PubMed ID: 19955831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants.
    Lisciandro JG; Prescott SL; Nadal-Sims MG; Devitt CJ; Pomat W; Siba PM; Tulic MC; Holt PG; Strickland D; van den Biggelaar AH
    PLoS One; 2012; 7(5):e36793. PubMed ID: 22649499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
    Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
    J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.
    Dold L; Zimmer L; Schwarze-Zander C; Boesecke C; Mohr R; Wasmuth JC; Ommer K; Gathof B; Krämer B; Nattermann J; Strassburg CP; Rockstroh JK; Spengler U; Langhans B
    J Mol Med (Berl); 2021 Jan; 99(1):147-158. PubMed ID: 33278000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.
    Angelone DF; Wessels MR; Coughlin M; Suter EE; Valentini P; Kalish LA; Levy O
    Pediatr Res; 2006 Aug; 60(2):205-9. PubMed ID: 16864705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors.
    Agrawal S; Gupta S
    J Clin Immunol; 2011 Feb; 31(1):89-98. PubMed ID: 20821041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presymptomatic differences in Toll-like receptor function in infants who have allergy.
    Prescott SL; Noakes P; Chow BW; Breckler L; Thornton CA; Hollams EM; Ali M; van den Biggelaar AH; Tulic MK
    J Allergy Clin Immunol; 2008 Aug; 122(2):391-9, 399.e1-5. PubMed ID: 18571707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Level of Toll-like receptor agonist exposure differentially determines chemokine production in humans.
    Lissitsyn Y; Becker AB; Kozyrskyj AL; HayGlass KT
    Can J Physiol Pharmacol; 2007 Jul; 85(7):739-46. PubMed ID: 17823637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole blood stimulation with Toll-like receptor (TLR)-7/8 and TLR-9 agonists induces interleukin-12p40 expression in plasmacytoid dendritic cells in rhesus macaques but not in humans.
    Koopman G; Beenhakker N; Burm S; Bouwhuis O; Bajramovic J; Sommandas V; Mudde G; Mooij P; 't Hart BA; Bogers WM
    Clin Exp Immunol; 2013 Oct; 174(1):161-71. PubMed ID: 23750720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.